TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 17999404

Group type: EXPERIMENTAL
Intervention: RT and immediate goserelin
Number of subjects: 945

Group type: COMPARATOR
Intervention: RT alone followed by goserelin at recurrence
Number of subjects: 945

Group type: EXPERIMENTAL
Intervention: BMI > or =25 to <30
Number of subjects: 945

Group type: EXPERIMENTAL
Intervention: BMI > or =30
Number of subjects: 945

Group type: EXPERIMENTAL
Intervention: BMI
Number of subjects: 945
Study: 15071488

Group type: EXPERIMENTAL
Intervention: Delapril-Manidipine combination
Number of subjects: 80

Group type: COMPARATOR
Intervention: Irbesartan-Hydrochlorothiazide combination
Number of subjects: 80
Study: 12479682

Group type: EXPERIMENTAL
Intervention: Drug trials in mania, specific interventions not detailed
Number of subjects: 0

Group type: COMPARATOR
Intervention: Various treatments, alone or in combination, specific interventions not detailed
Number of subjects: 0
Study: 9619120

Group type: EXPERIMENTAL
Intervention: Curcumin 2 g/kg + Piperine 20 mg/kg in rats
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Curcumin 2 g + Piperine 20 mg in humans
Number of subjects: 0
Study: 7862267

Group type: EXPERIMENTAL
Intervention: Caffeine citrate (1 mg/kg body weight)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Caffeine citrate (2 mg/kg body weight)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Caffeine citrate (3 mg/kg body weight)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Caffeine citrate (4 mg/kg body weight)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study: 2919758

Group type: EXPERIMENTAL
Intervention: Midazolam (0.3 mg kg‐1)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Thiopental (4 mg kg‐1)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Midazolam and Thiopental
Number of subjects: 40

Group type: COMPARATOR
Intervention: Thiopental
Number of subjects: 40
Study: 28653428

Group type: EXPERIMENTAL
Intervention: Dextroamphetamine (10 mg daily for 3 weeks)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo (identical to DEX)
Number of subjects: 32
Study: 27187320

Group type: EXPERIMENTAL
Intervention: 0.5 mg E + 15 mg P (Group A)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: 1 mg E + 20 mg P (Group B)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: 1 mg E + 30 mg P (Group C)
Number of subjects: 84
Study: 24730653

Group type: EXPERIMENTAL
Intervention: Chronic Pain Self‐Management Program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tailored Physical Activity
Number of subjects: 0
Study: 23715519

Group type: EXPERIMENTAL
Intervention: Dietary intervention (supplementation with 1,200 mg n‐3 LCPUFAs per day and instructions to reduce arachidonic acid (AA) intake)
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Dietary intervention
Number of subjects: 208

Group type: COMPARATOR
Intervention: Control (habitual diet)
Number of subjects: 208
Study: 21210111

Group type: EXPERIMENTAL
Intervention: Conventional staging + PET/CT
Number of subjects: 189

Group type: COMPARATOR
Intervention: Conventional staging
Number of subjects: 189
Study: 18502239

Group type: EXPERIMENTAL
Intervention: Motivational interviewing with discussion of values
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Motivational interviewing without discussion of values
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Motivational interviewing (both groups)
Number of subjects: 20
Study: 17158425

Group type: EXPERIMENTAL
Intervention: High iron supplementation
Number of subjects: 1657

Group type: EXPERIMENTAL
Intervention: Low iron supplementation
Number of subjects: 1657

Group type: COMPARATOR
Intervention: No added iron
Number of subjects: 1657

Group type: EXPERIMENTAL
Intervention: Overall population
Number of subjects: 1657
Study: 12660532

Group type: EXPERIMENTAL
Intervention: Bezafibrate
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Gemfibrozil
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Fenofibrate
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Pravastatin
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Fluvastatin
Number of subjects: 106
Study: 10714846

Group type: EXPERIMENTAL
Intervention: pethidine 17.5 mg
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: pentazocine 7.5 mg
Number of subjects: 45

Group type: COMPARATOR
Intervention: normal saline
Number of subjects: 45
Study: 9175960

Group type: EXPERIMENTAL
Intervention: bupivacaine with fentanyl 1 microgram ml‐1
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: bupivacaine with fentanyl 2 micrograms ml‐1
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: bupivacaine with fentanyl 3 micrograms ml‐1
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: bupivacaine with fentanyl 4 micrograms ml‐1
Number of subjects: 223

Group type: COMPARATOR
Intervention: plain bupivacaine
Number of subjects: 223
Study: 1313120

Group type: EXPERIMENTAL
Intervention: Prostaglandin E1 (PGE1) infusion at a rate of 30 ng.kg‐1.min‐1 during cardiopulmonary bypass (CPB)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Saline infusion (Control group)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Both groups (PGE1 and Control)
Number of subjects: 19
Study: 3886308

Group type: EXPERIMENTAL
Intervention: Amitriptyline (25 mg 3-times daily)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 31353814

Group type: EXPERIMENTAL
Intervention: VOICE risk score (scores ≥5)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: VOICE risk score
Number of subjects: 0
Study: 28419448

Group type: EXPERIMENTAL
Intervention: Match condition (tablet)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Mismatch condition (felt board)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Working Memory (WM) assessment
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Contextual match
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Proactive interference
Number of subjects: 42
Study: 27022113

Group type: EXPERIMENTAL
Intervention: Acupuncture plus enhanced self-care
Number of subjects: 190

Group type: COMPARATOR
Intervention: Enhanced self-care
Number of subjects: 190
Study: 25006118

Group type: EXPERIMENTAL
Intervention: Newsletter (N)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Newsletter and growth monitoring (N + GM)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Newsletter and growth monitoring plus family-based behavioral counseling (N + GM + BC)
Number of subjects: 22
Study: 22695973

Group type: EXPERIMENTAL
Intervention: Single-leg spica cast
Number of subjects: 52

Group type: COMPARATOR
Intervention: Double-leg spica cast
Number of subjects: 52
Study: 20884164

Group type: EXPERIMENTAL
Intervention: Metastatic lymph node ratio (LNR)
Number of subjects: 605

Group type: EXPERIMENTAL
Intervention: LNR value of 0.60
Number of subjects: 605

Group type: COMPARATOR
Intervention: Pre-operative radiotherapy
Number of subjects: 605
Study: 19621648

Group type: EXPERIMENTAL
Intervention: Pilates breathing exercise method
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 17166985

Group type: EXPERIMENTAL
Intervention: Self-management education program 'Living Well with COPD' with ongoing supervision by a case manager
Number of subjects: 191
Study: 14738640

Group type: EXPERIMENTAL
Intervention: Mirena (levonorgestrel‐releasing intrauterine device) inserted after endometrial resection
Number of subjects: 95

Group type: COMPARATOR
Intervention: Control group (no further treatment after endometrial resection)
Number of subjects: 95
Study: 10920832

Group type: EXPERIMENTAL
Intervention: APN interventions (standard care plus APN interventions based on Brooten's cost‐quality model)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Standard medical care
Number of subjects: 210
Study: 9012304

Group type: EXPERIMENTAL
Intervention: Etomidate in lipid emulsion (0.51 mg/kg)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Propofol in long chain triglyceride emulsion (3.04 mg/kg)
Number of subjects: 100
Study: 1555871

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 878

Group type: EXPERIMENTAL
Intervention: Atenolol (50 mg)
Number of subjects: 878

Group type: EXPERIMENTAL
Intervention: Chlorthalidone (25 mg)
Number of subjects: 878
Study: 3884690

Group type: EXPERIMENTAL
Intervention: Fluocortin butyl (FCB) 2 mg per day
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: Fluocortin butyl (FCB) 4 mg per day
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: Fluocortin butyl (FCB) 8 mg per day
Number of subjects: 235

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 235
Study: 30980471

Group type: EXPERIMENTAL
Intervention: Struts thickness ≤81 nm
Number of subjects: 52006

Group type: EXPERIMENTAL
Intervention: Mean number of connectors >2.5
Number of subjects: 52006

Group type: EXPERIMENTAL
Intervention: Average number of crowns <7.5
Number of subjects: 52006
Study: 31219949

Group type: EXPERIMENTAL
Intervention: Concentration-Controlled Dosing (CC) of EC-MPS
Number of subjects: 19

Group type: COMPARATOR
Intervention: Fixed-Dosing (FD) of EC-MPS
Number of subjects: 19
Study: 28724273

Group type: EXPERIMENTAL
Intervention: Inhaled Salbutamol (200 micrograms)
Number of subjects: 20
Study: 25781214

Group type: EXPERIMENTAL
Intervention: Creatine supplementation
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 23234408

Group type: EXPERIMENTAL
Intervention: SAFA diet (29 caloric % SAFA)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: PUFA diet (25 caloric % PUFA)
Number of subjects: 15
Study: 21240818

Group type: EXPERIMENTAL
Intervention: Weight-shifting training (30-min sessions, 3 sessions/week, 4 weeks)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 63
Study: 19228175

Group type: EXPERIMENTAL
Intervention: Lorazepam 4.5 mg/day
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Paroxetine 20 mg/day
Number of subjects: 169

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Both active drugs
Number of subjects: 169
Study: 16966491

Group type: EXPERIMENTAL
Intervention: ezetimibe (10 mg/day)
Number of subjects: 18

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 18
Study: 14985218

Group type: EXPERIMENTAL
Intervention: Zinc (10 mg as acetate, twice daily for 5 days)
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Vitamin A (10,000 microg retinol equivalents, twice daily for 4 days)
Number of subjects: 153

Group type: COMPARATOR
Intervention: Control (placebo for zinc and vitamin A)
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Zinc treatment
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Vitamin A treatment
Number of subjects: 153
Study: 11380277

Group type: EXPERIMENTAL
Intervention: Isometric quadriceps femoris muscle exercise
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Isotonic quadriceps femoris muscle exercise
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Isokinetic quadriceps femoris muscle exercise
Number of subjects: 24
Study: 9024473

Group type: EXPERIMENTAL
Intervention: COPE intervention
Number of subjects: 30

Group type: COMPARATOR
Intervention: Comparison program
Number of subjects: 30
Study: 8435972

Group type: EXPERIMENTAL
Intervention: Iodixanol
Number of subjects: 95

Group type: COMPARATOR
Intervention: Iopromide
Number of subjects: 95
Study: 3535611

Group type: EXPERIMENTAL
Intervention: Levobunolol 0.5%
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Levobunolol 1%
Number of subjects: 51

Group type: COMPARATOR
Intervention: Timolol 0.5%
Number of subjects: 51
Study: 29357921

Group type: EXPERIMENTAL
Intervention: Nurse sessions (attending all three sessions)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Postal group (diary return)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Nurse group (diary return)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Regular pedometer use (postal group)
Number of subjects: 45
Study: 25768808

Group type: EXPERIMENTAL
Intervention: Multifactorial injury prevention intervention (injury awareness programme and preventive strategies) implemented over one academic year.
Number of subjects: 343

Group type: EXPERIMENTAL
Intervention: Multifactorial injury prevention intervention
Number of subjects: 343

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 343
Study: 23949208

Group type: EXPERIMENTAL
Intervention: Collagen hydrolysate (CH) 2.5 g
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Collagen hydrolysate (CH) 5.0 g
Number of subjects: 69

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Collagen hydrolysate (CH) (both dosages)
Number of subjects: 69
Study: 22789168

Group type: EXPERIMENTAL
Intervention: Critical Time Intervention (CTI)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 60
Study: 20564162

Group type: EXPERIMENTAL
Intervention: Paclitaxel (100 mg/m2 iv every 2 weeks)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Pegylated liposomal doxorubicin (PLD) (20 mg/m2 iv every 3 weeks)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Paclitaxel
Number of subjects: 73
Study: 17098206

Group type: EXPERIMENTAL
Intervention: Zyoptix XP microkeratome
Number of subjects: 41

Group type: COMPARATOR
Intervention: Intralase laser
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 41
Study: 16224085

Group type: EXPERIMENTAL
Intervention: Intravenous heparin sodium
Number of subjects: 418

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 418
Study: 12192660

Group type: EXPERIMENTAL
Intervention: Left temporal lobe epilepsy (LTE) group
Number of subjects: 14

Group type: COMPARATOR
Intervention: Right temporal lobe epilepsy (RTE) group
Number of subjects: 14
Study: 10410403

Group type: EXPERIMENTAL
Intervention: 500 ml of dextran 40
Number of subjects: 60

Group type: COMPARATOR
Intervention: 1000 ml of lactated Ringer's solution
Number of subjects: 60
Study: 7503169

Group type: EXPERIMENTAL
Intervention: Fetal acoustic stimulation to maternal abdomen
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control (fetal acoustic stimulation to nurse's arm)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Fetal acoustic stimulation to maternal abdomen (crossover trial)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo fetal acoustic stimulation
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Combined data from original and crossover trials
Number of subjects: 26
Study: 1688835

Group type: COMPARATOR
Intervention: Normal saline crystalloid solution
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Hetastarch colloid solution
Number of subjects: 21
Study: 7428410

Group type: EXPERIMENTAL
Intervention: Propranolol (40 mg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Acebutolol (100 mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 30693406

Group type: EXPERIMENTAL
Intervention: Osteoplasty alone (group 2)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: K-wires augmented osteoplasty (group 3)
Number of subjects: 30

Group type: COMPARATOR
Intervention: No consolidation (group 1)
Number of subjects: 30
Study: 29653900

Group type: EXPERIMENTAL
Intervention: Exergame cycling
Number of subjects: 68

Group type: COMPARATOR
Intervention: Standard bike in front of TV
Number of subjects: 68
Study: 26259074

Group type: EXPERIMENTAL
Intervention: Telemedicine-based symptom reporting program
Number of subjects: 79

Group type: COMPARATOR
Intervention: Usual medical care (control group)
Number of subjects: 79
Study: 25079465

Group type: EXPERIMENTAL
Intervention: Synbiotic food (n=26)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control food (n=26)
Number of subjects: 52
Study: 22032759

Group type: EXPERIMENTAL
Intervention: Desvenlafaxine 25 mg/d
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Desvenlafaxine 50 mg/d
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Desvenlafaxine 50 mg/d every other day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Desvenlafaxine 50/25 mg/d
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Desvenlafaxine 50 mg/d - placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: No taper
Number of subjects: 0
Study: 19330771

Group type: EXPERIMENTAL
Intervention: Clinical tool based on age of child, excess age-specific respiratory rate at baseline and at 24 hr of hospitalization; Validation sample size: 813 children.
Number of subjects: 1702

Group type: EXPERIMENTAL
Intervention: Clinical tool based on age of child, excess age-specific respiratory rate at baseline and at 24 hr of hospitalization; Development sample size: 889 children.
Number of subjects: 1702
Study: 17230059

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Duration and type of chelation therapy
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Age of beginning chelation therapy
Number of subjects: 67
Study: 15494760

Group type: EXPERIMENTAL
Intervention: Educational workshop
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Structured prompting
Number of subjects: 0

Group type: COMPARATOR
Intervention: Experimental group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 12153824

Group type: EXPERIMENTAL
Intervention: Methylphenidate (moderate and high doses)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 10201459

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg daily
Number of subjects: 446

Group type: COMPARATOR
Intervention: Ranitidine 300 mg twice daily
Number of subjects: 446

Group type: EXPERIMENTAL
Intervention: Omeprazole 10 mg daily (maintenance)
Number of subjects: 446

Group type: COMPARATOR
Intervention: Ranitidine 150 mg twice daily (maintenance)
Number of subjects: 446
Study: 8519715

Group type: EXPERIMENTAL
Intervention: Fentanyl 15 micrograms with 80 mg hyperbaric lidocaine
Number of subjects: 28

Group type: COMPARATOR
Intervention: Normal saline with 80 mg hyperbaric lidocaine
Number of subjects: 28
Study: 2167110

Group type: EXPERIMENTAL
Intervention: Transcatheter arterial embolization (TAE) using iodized oil (Lipiodol) mixed with anticancer agent (ACA)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Hepatic artery infusion (HAI) of anticancer agent (ACA)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Oral chemotherapy following TAE or HAI
Number of subjects: 85
Study: 206214

Group type: EXPERIMENTAL
Intervention: Surgical excision of the tumor, chemotherapy, and radiation therapy as per study protocol
Number of subjects: 606

Group type: EXPERIMENTAL
Intervention: Surgical excision of the tumor
Number of subjects: 606

Group type: EXPERIMENTAL
Intervention: Early ligation of the renal vein
Number of subjects: 606

Group type: EXPERIMENTAL
Intervention: Incomplete removal of tumor
Number of subjects: 606
Study: 31179920

Group type: EXPERIMENTAL
Intervention: Gaze and Postural Stability (GPS) intervention program
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard of Care (SOC) rehabilitation program
Number of subjects: 50
Study: 28841230

Group type: EXPERIMENTAL
Intervention: Drug-Eluting Stents (DES)
Number of subjects: 599

Group type: COMPARATOR
Intervention: Bare-Metal Stents (BMS)
Number of subjects: 599
Study: 26530929

Group type: EXPERIMENTAL
Intervention: Personal coaching enhanced by smartphone self-monitoring (PC)
Number of subjects: 365

Group type: COMPARATOR
Intervention: Control
Number of subjects: 365

Group type: EXPERIMENTAL
Intervention: Cell phone intervention delivered by interactive smartphone application (CP)
Number of subjects: 365
Study: 23458391

Group type: COMPARATOR
Intervention: 150 W xenon arc solar simulator
Number of subjects: 30

Group type: COMPARATOR
Intervention: 300 W xenon arc solar simulator
Number of subjects: 30
Study: 21200346

Group type: EXPERIMENTAL
Intervention: Individuals with Down syndrome (DS)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Individuals without Down syndrome (non-DS)
Number of subjects: 18
Study: 19666698

Group type: EXPERIMENTAL
Intervention: Combination therapy with T4 (50 microg) and T3 (20 microg) for 12 weeks
Number of subjects: 59

Group type: COMPARATOR
Intervention: T4 monotherapy for 12 weeks
Number of subjects: 59
Study: 17459561

Group type: EXPERIMENTAL
Intervention: Voice Advisory Manikin (VAM)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standardized Human Instruction (SHI)
Number of subjects: 50
Study: 15558584

Group type: EXPERIMENTAL
Intervention: Neoral (cyclosporine) + prednisolone (group 1)
Number of subjects: 174

Group type: COMPARATOR
Intervention: Neoral + placebo (group 2)
Number of subjects: 174
Study: 15266173

Group type: EXPERIMENTAL
Intervention: 185 MBq diagnostic scan (Dscan) 4-11 days before 131I ablation (Group A)
Number of subjects: 245

Group type: COMPARATOR
Intervention: 131I ablation directly after thyroidectomy (Group B)
Number of subjects: 245
Study: 10399203

Group type: EXPERIMENTAL
Intervention: Mann-Whitney U-test for clustered data
Number of subjects: 0
Study: 7737935

Group type: EXPERIMENTAL
Intervention: Pygmalion condition (leaders believed trainees had higher potential)
Number of subjects: 0
Study: 1852141

Group type: EXPERIMENTAL
Intervention: Nimesulide (100 mg bid orally)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 7193603

Group type: EXPERIMENTAL
Intervention: Combined oral contraceptive 20/250 (EE/NG ratio 0.08)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Combined oral contraceptive 30/250 (EE/NG ratio 0.12)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Combined oral contraceptive 30/150 (EE/NG ratio 0.20)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Three-phase drug (EE/NG ratio 0.35)
Number of subjects: 98
Study: 30702853

Group type: EXPERIMENTAL
Intervention: Real world data (RWD) studies on drug repurposing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PaWei app platform
Number of subjects: 0
Study: 27568321

Group type: EXPERIMENTAL
Intervention: Standard surgery (JCOG9501)
Number of subjects: 678

Group type: EXPERIMENTAL
Intervention: Standard surgery (JCOG9502)
Number of subjects: 678

Group type: COMPARATOR
Intervention: Experimental surgery (JCOG9501)
Number of subjects: 678

Group type: COMPARATOR
Intervention: Experimental surgery (JCOG9502)
Number of subjects: 678

Group type: EXPERIMENTAL
Intervention: Higher hospital gastrectomy volume (JCOG9501)
Number of subjects: 678

Group type: EXPERIMENTAL
Intervention: Higher hospital gastrectomy volume (JCOG9502)
Number of subjects: 678
Study: 26378926

Group type: EXPERIMENTAL
Intervention: Probiotic supplementation with Ecologic® Panda (B. bifidum W23, B. lactis W52, Lc. Lactis W58)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Atopic children
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Both groups (probiotic and placebo)
Number of subjects: 99